Pentoxifylline for vascular health: a brief review of the literature.
McCarty MF1, O'Keefe JH2, DiNicolantonio JJ2
Author information
Open Heart, 08 Feb 2016, 3(1):e000365
DOI: 10.1136/openhrt-2015-000365 PMID: 26870389 PMCID: PMC4746528
https://europepmc.org/article/pmc/4746528
Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019
Ghasemnejad-Berenji M.a · Pashapour S.b · Sadeghpour S.c
Author affiliations
Corresponding Author
Keywords: Severe acute respiratory syndrome coronavirus-2Coronavirus disease 2019Pentoxifylline
Med Princ Pract 2021;30:98–100
https://doi.org/10.1159/000512234
https://www.karger.com/Article/FullText/512234
A Combined Treatment Effect of Cilostazol and Pentoxifylline in the Treatment of Peripheral Vascular Disease
Jalpa Suthar Birju Shah Ritu Ranjan
Asian Journal of Medicine and Health, Page 74-80
DOI: 10.9734/ajmah/2022/v20i1130528
Published: 3 September 2022
https://journalajmah.com/index.php/AJMAH/article/view/731
The rest pain: Out of 52 patients, 42 (80.7%) showed improvement in six months.
For intermediate claudication 73% patients showed improvement in six months.
Zilast (Cilostazeol)
Trental, Kinetal (Pentoxifylline)
Ud 20.10.2022
pub 10.9.2022
No comments:
Post a Comment